Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velpatasvir/Sofosbuvir in HCV Patients with Recent Injection Drug Use
NCT05895448Phase 4Unknown
- Sponsor
- Center for the Study of Hepatitis C
- Start
- Mar 2018
- Primary completion
- Nov 2023
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir, sofosbuvir in hepatitis C (HCV), sponsored by Center for the Study of Hepatitis C. Status: unknown.
02
Drugs
velpatasvirsofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT05895448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05895448.